Cargando…

A Tumor-Immune Interaction Model for Synergistic Combinations of Anti PD-L1 and Ionizing Irradiation Treatment

Combination therapy with immune checkpoint blockade and ionizing irradiation therapy (IR) generates a synergistic effect to inhibit tumor growth better than either therapy does alone. We modeled the tumor-immune interactions occurring during combined IT and IR based on the published data from Deng e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Byun, Jong Hyuk, Yoon, In-Soo, Jeong, Yong Dam, Kim, Sungchan, Jung, Il Hyo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7558639/ https://www.ncbi.nlm.nih.gov/pubmed/32878065 http://dx.doi.org/10.3390/pharmaceutics12090830

Ejemplares similares

A mathematical model for assessing the effectiveness of controlling relapse in Plasmodium vivax malaria endemic in the Republic of Korea
por: Kim, Sungchan, et al.
Publicado: (2020)

Role of BCLAF‐1 in PD‐L1 stabilization in response to ionizing irradiation
por: Ma, Zhao, et al.
Publicado: (2021)

Evaluation of COVID-19 epidemic outbreak caused by temporal contact-increase in South Korea
por: Kim, Sungchan, et al.
Publicado: (2020)

Biological effect of an alternating electric field on cell proliferation and synergistic antimitotic effect in combination with ionizing radiation
por: Kim, Eun Ho, et al.
Publicado: (2016)

Extended transit compartment model to describe tumor delay using Coxian distribution
por: Byun, Jong Hyuk, et al.
Publicado: (2022)

Fractional transit compartment model for describing drug delayed response to tumors using Mittag-Leffler distribution on age-structured PKPD model
por: Byun, Jong Hyuk, et al.
Publicado: (2022)

Modeling to capture bystander-killing effect by released payload in target positive tumor cells
por: Byun, Jong Hyuk, et al.
Publicado: (2019)

Molecular mechanism of PD-1/PD-L1 blockade via anti-PD-L1 antibodies atezolizumab and durvalumab
por: Lee, Hyun Tae, et al.
Publicado: (2017)

How Does Ionizing Irradiation Contribute to the Induction of Anti-Tumor Immunity?
por: Rubner, Yvonne, et al.
Publicado: (2012)

Sunitinib Malate Synergistically Potentiates Anti-Tumor Effect of Gemcitabine in Human Bladder Cancer Cells
por: Yoon, Cheol Yong, et al.
Publicado: (2011)

Synergistic enhancement of NK cell-mediated cytotoxicity by combination of histone deacetylase inhibitor and ionizing radiation
por: Son, Cheol-Hun, et al.
Publicado: (2014)

Anti-PD-1/Anti-PD-L1 Drugs and Radiation Therapy: Combinations and Optimization Strategies
por: Boustani, Jihane, et al.
Publicado: (2021)

Research on the Synergistic Effect of Total Ionization and Displacement Dose in GaN HEMT Using Neutron and Gamma-Ray Irradiation
por: Chen, Rui, et al.
Publicado: (2022)

Synergistic effects of tetrandrine combined with ionizing radiation on a murine colorectal carcinoma-bearing mouse model
por: Lin, Wei-Chan, et al.
Publicado: (2018)

Synergistic inhibition of pancreatic cancer with anti-PD-L1 and c-Myc inhibitor JQ1
por: Pan, Yu, et al.
Publicado: (2019)

Synergistic combination of targeted nano-nuclear-reactors and anti-PD-L1 nanobodies evokes persistent T cell immune activation for cancer immunotherapy
por: Zhu, Lipeng, et al.
Publicado: (2022)

An immune therapy model for effective treatment on inflammatory bowel disease
por: Park, Anna, et al.
Publicado: (2020)

Overexpression of PD-L1 and PD-L2 Is Associated with Poor Prognosis in Patients with Hepatocellular Carcinoma
por: Jung, Hae Il, et al.
Publicado: (2017)

Implication of combined PD-L1/PD-1 blockade with cytokine-induced killer cells as a synergistic immunotherapy for gastrointestinal cancer
por: Dai, Congqi, et al.
Publicado: (2016)

The Synergistic Potential of Combining PD-1/PD-L1 Immune Checkpoint Inhibitors with NOD2 Agonists in Alzheimer’s Disease Treatment
por: Ghareghani, Majid, et al.
Publicado: (2023)

Antioxidant Approaches to Management of Ionizing Irradiation Injury
por: Greenberger, Joel, et al.
Publicado: (2015)

Combination checkpoint therapy with anti-PD-1 and anti-BTLA results in a synergistic therapeutic effect against murine glioblastoma
por: Choi, John, et al.
Publicado: (2021)

Combined SEP and anti-PD-L1 antibody produces a synergistic antitumor effect in B16-F10 melanoma-bearing mice
por: Hu, Zhengping, et al.
Publicado: (2018)

Multifunctional Nanoparticles-Mediated PTT/PDT Synergistic Immune Activation and Antitumor Activity Combined with Anti-PD-L1 Immunotherapy for Breast Cancer Treatment
por: Kong, Cunqing, et al.
Publicado: (2022)

Co-administration of combretastatin A4 nanoparticles and anti-PD-L1 for synergistic therapy of hepatocellular carcinoma
por: Zhao, Bonan, et al.
Publicado: (2021)

Anlotinib Enhances the Antitumor Activity of High-Dose Irradiation Combined with Anti-PD-L1 by Potentiating the Tumor Immune Microenvironment in Murine Lung Cancer
por: Yuan, Meng, et al.
Publicado: (2022)

Rational combination of oncolytic vaccinia virus and PD-L1 blockade works synergistically to enhance therapeutic efficacy
por: Liu, Zuqiang, et al.
Publicado: (2017)

Targeted Nanobubbles of PD-L1 mAb Combined with Doxorubicin as a Synergistic Tumor Repressor in Hepatocarcinoma
por: Chen, Yezi, et al.
Publicado: (2022)

Anti-PD-1 Therapy Response Predicted by the Combination of Exosomal PD-L1 and CD28
por: Zhang, Chaoxu, et al.
Publicado: (2020)

Rationale of combination of anti-PD-1/PD-L1 antibody therapy and radiotherapy for cancer treatment
por: Sato, Hiro, et al.
Publicado: (2020)

Synergistic anti-tumor efficacy by combination therapy of a self-assembled nanogel vaccine with an immune checkpoint anti-PD-1 antibody
por: Miura, Risako, et al.
Publicado: (2020)

Improving Anti-PD-1/PD-L1 Therapy for Localized Bladder Cancer
por: de Jong, Florus C., et al.
Publicado: (2021)

Anti-PD-L1 peptide-conjugated prodrug nanoparticles for targeted cancer immunotherapy combining PD-L1 blockade with immunogenic cell death
por: Moon, Yujeong, et al.
Publicado: (2022)

ABC130 Total Ionizing Dose Irradiation Campaign
por: QUIRK, Nicholas Patrick
Publicado: (2015)

Effects of Ionizing Irradiation on Mouse Diaphragmatic Skeletal Muscle
por: Zhou, Tingyang, et al.
Publicado: (2017)

Optimizing the Treatment Schedule of Radiotherapy Combined With Anti-PD-1/PD-L1 Immunotherapy in Metastatic Cancers
por: Kong, Yuehong, et al.
Publicado: (2021)

Combination therapy for pancreatic cancer: anti-PD-(L)1-based strategy
por: Liu, Lingyue, et al.
Publicado: (2022)

Efficacy and Safety of PD-1/PD-L1 Checkpoint Inhibitors versus Anti-PD-1/PD-L1 Combined with Other Therapies for Tumors: A Systematic Review
por: Zhang, Yiru, et al.
Publicado: (2023)

Synergistic anti-tumor effects of arsenic trioxide and blue LED irradiation on human osteosarcoma
por: Feng, Chao, et al.
Publicado: (2019)

Hexokinase-II Inhibition Synergistically Augments the Anti-tumor Efficacy of Sorafenib in Hepatocellular Carcinoma
por: Yoo, Jeong-Ju, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_omsoasigse5vietkigp02mdis2